Client News

CorTec Announces Successful Second Human Implantation of Its Brain-Computer Interface (BCI) System

Newron Notes Publication Highlighting Clinically Meaningful Benefits of Evenamide as an Adjunctive Treatment in Schizophrenia

InflaRx Announces Participation in February Investor Conferences

Rentschler Biopharma appoints Detra Glinatsis as Head of Business Development U.S.

Mallia selected as Innovation Tank finalist at IMCAS World Congress 2026

Rentschler Biopharma Announces Executive Board Changes and Next Phase of Corporate Strategy

ARTCLINE appoints Peter Llewellyn-Davies as Chairman of the Supervisory Board and accelerates commercialization of innovative sepsis therapy

smartbax in-licenses lead antibacterial compound targeting Gram-negative infections from Aicuris

Andera Partners’ Portfolio Company Exciva Secures €51 Million Series B to Advance Clinical Program for Alzheimer’s-Related Agitation

DEBRA Research and the University Medical Center Groningen Launch Dedicated Clinical Trial Site for Epidermolysis Bullosa